Iron and folic acid supplements and reduced early neonatal deaths in Indonesia
Related Experiment Video
Updated: Jun 11, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Christiana R Titaley1, Michael J Dibley, Christine L Roberts
1Sydney School of Public Health, Edward Ford Building (A27), University of Sydney, NSW 2006, Australia. ctitaley@health.usyd.edu.au
Insights
Maternal iron and folic acid supplementation significantly reduced early neonatal death risk in Indonesia. This intervention, crucial for infant survival, could benefit other low- and middle-income countries.
Area of Science:
- Maternal and child health
- Public health interventions
- Neonatal mortality research
Background:
- Early neonatal death remains a significant global health challenge.
- Antenatal care, iron-folic acid, and tetanus toxoid vaccination are key interventions during pregnancy.
Purpose of the Study:
- To investigate the impact of antenatal care, iron and folic acid (IFA) supplementation, and tetanus toxoid (TT) vaccination on early neonatal death risk in Indonesia.
Main Methods:
- Analysis of pooled data from Indonesian Demographic and Health Surveys (1994, 1997, 2002-2003).
- Inclusion of singleton infants and their mothers.
- Multivariate Cox proportional hazards models to identify risk factors for early neonatal death.
Main Results:
- A total of 40,576 infants were analyzed, with 442 early neonatal deaths.
- Maternal IFA supplementation showed a significant protective effect, reducing early neonatal death risk (HR: 0.53; 95% CI: 0.36-0.77).
- Lack of IFA supplementation contributed to 20% of early neonatal deaths in Indonesia.
Conclusions:
- Iron and folic acid supplementation during pregnancy is a critical intervention for reducing early neonatal mortality in Indonesia.
- The findings suggest that IFA supplementation can be a highly effective strategy in other low- and middle-income countries.
Objective:
To examine the relationship between antenatal care, iron and folic acid supplementation and tetanus toxoid vaccination during pregnancy in Indonesia and the risk of early neonatal death (death in days 0-6 of life).
Methods:
We analysed pooled data on neonatal survival in singleton infants born in the 5 years before each of the Indonesian demographic and health surveys of 1994, 1997 and 2002-2003. Only the most recently born infant of each mother was included. Multivariate Cox proportional hazards models were used to identify factors linked to early neonatal death.
Findings:
Of the 40 576 infants included, 442 experienced early neonatal death. After adjustment, the risk of early neonatal death was significantly reduced for infants of mothers who received either any form of antenatal care (hazard ratio, HR: 0.48; 95% confidence interval, CI: 0.31-0.73), any quantity of iron and folic acid (HR: 0.53; 95% CI: 0.36-0.77) or >or= 2 tetanus toxoid injections (HR: 0.66; 95% CI: 0.48-0.92). When we analysed different combinations of these measures, iron and folic acid supplementation provided the main protective effect: early neonatal deaths were still significantly reduced among infants whose mothers received iron and folic acid supplements but no other form of antenatal care (HR: 0.10; 95% CI: 0.01-0.67), or the supplements but < 2 tetanus toxoid injections (HR: 0.46; 95% CI: 0.29-0.73). Subsequent analysis showed that 20% of early neonatal deaths in Indonesia could be attributed to a lack of iron and folic acid supplementation during pregnancy.
Conclusion:
Iron and folic acid supplementation during pregnancy in Indonesia significantly reduced the risk of early neonatal death and could also do so in other low- and middle-income countries.
Related Concept Videos
Vitamins
Environmental Influences on Intelligence
Development of the Oral Microbiota
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Teratogenicity
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

